Colistimethate sodium adverse reactions

Colistimethate sodium
COLY-MYCIN M'® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

Adverse Reactions

The following adverse reactions have been reported:

• Gastrointestinal: gastrointestinal upset

• Nervous System: tingling of extremities and tongue, slurred speech, dizziness, vertigo and paresthesia

• Integumentary: generalized itching, urticaria and rash

• Body as a Whole: fever

• Laboratory Deviations: increased blood urea nitrogen (BUN), elevated creatinine and decreased creatinine clearance

• Respiratory System: respiratory distress and apnea

• Renal System: nephrotoxicity and decreased urine output

For medical advice about adverse reactions contact your medical professional. To report SUSPECTED ADVERSE REACTIONS, contact JHP at 1-866-923-2547 or MEDWATCH at 1-800-FDA-1088 (1-800-332-1088) or http://www.fda.gov/medwatch/.

References

Adapted from the FDA Package Insert.